Hydatid Cyst, HepaticHydatid cystNCT07369674
Epidemiological Study of Hydatid Cyst in Najaf City, Iraq
An observational study of Hydatid Cyst, Hepatic, run by Al-Kafeel University at 1 site in Iraq.
Trial summary
Background Cystic echinococcosis (hydatid cyst) is a significant zoonotic disease endemic to Iraq. Understanding the localized clinical and epidemiological trends is vital for improving surgical outcomes and public health strategies. Read more about this study
- Who is it for?
- Ages 9 years and older
- Conditions the study is for
- Hydatid Cyst, Hepatic
- How many people
- 350 participants
- Where
- 1 siteIraq
- Study dates
- 2 Feb 2021to 5 Mar 2025
- How long will I take part?
- 12 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 9 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: This retrospective, observational study was conducted on a total of 350 patients diagnosed with liver hydatid cysts. The study was carried out at multiple centers in Najaf City, Iraq, including major governmental surgical hospitals and specialized centers, covering the period from February 2021 to June 2024.
Who may be able to join
- All patients of any age or gender with a radiologically or surgically confirmed diagnosis of liver hydatid cyst
Who cannot join
- Patients with hydatid cysts located exclusively in extra-hepatic sites (e.g., brain, lung, bone, spleen, or muscle). Patients with severe chronic comorbidities or incomplete medical records were also excluded to ensure data integrity
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Epidemiological and Clinical Characteristics of Patients With Hepatic Hydatid Cysts in an Endemic Area: A Multi-Center Investigation in Najaf City, Iraq.
Background Cystic echinococcosis (hydatid cyst) is a significant zoonotic disease endemic to Iraq. Understanding the localized clinical and epidemiological trends is vital for improving surgical outcomes and public health strategies.
Objective To determine the epidemiological and clinical profile of patients diagnosed with liver hydatid cysts within the hospitals of Najaf City, Iraq.
Read the detailed description
Patients and Methods This retrospective observational study analyzed the records of 350 patients treated for liver hydatid cysts across multiple hospitals in Najaf, Iraq, from February 2021 to June 2024. Data were extracted from official patient records, including sociodemographic characteristics, clinical presentation, cyst morphology, and postoperative complications.
- Conditions
- Hydatid Cyst, Hepatic
- Medical subject headings
- Echinococcosis, Hepatic
What is being measured
The primary outcome is the main question the study is designed to answer.
To determine the epidemiological and clinical profile of patients diagnosed with liver hydatid cysts within the hospitals of Najaf City, Iraq.
This retrospective observational study analyzed the records of 350 patients treated for liver hydatid cysts across multiple hospitals in Najaf, Iraq, from February 2021 to June 2024.
Measured: February 2021 to June 2024
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jan 2026
- Study start2 Feb 2021
- Primary completion5 Jun 2024
- Study completion5 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hydatid Cyst, HepaticStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 350 participants (actual)
- Target duration
- 12 Months
Sponsor and investigators
- Lead sponsor
- Al-Kafeel University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Samer Al Hakkak, Al-Kafeel University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07369674
- Sponsor's protocol ID
- University of Alkafeel
- Other IDs
- self
- Acronym
- Hydatid cyst
- Status last verified
- Jan 2026
- First submitted
- 5 Jan 2026
- Last updated
- 30 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: undecided
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Epidemiological and Clinical Characteristics of Patients With Hepatic Hydatid Cysts in an Endemic Area: A Multi-Center Investigation in Najaf City, Iraq.
- ClinicalTrials.gov ID
- NCT07369674
- Acronym / sponsor ID
- Hydatid cyst / University of Alkafeel
- Conditions
- Hydatid Cyst, Hepatic
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 350 participants (actual)
- Lead sponsor
- Al-Kafeel UniversityUniversity, hospital or other
- Study start
- 2 Feb 2021 (actual)
- Primary completion
- 5 Jun 2024 (actual)
- Study completion
- 5 Mar 2025 (actual)
- First posted
- 27 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background Cystic echinococcosis (hydatid cyst) is a significant zoonotic disease endemic to Iraq. Understanding the localized clinical and epidemiological trends is vital for improving surgical outcomes and public health strategies.
Objective To determine the epidemiological and clinical profile of patients diagnosed with liver hydatid cysts within the hospitals of Najaf City, Iraq.
Detailed description
Patients and Methods This retrospective observational study analyzed the records of 350 patients treated for liver hydatid cysts across multiple hospitals in Najaf, Iraq, from February 2021 to June 2024. Data were extracted from official patient records, including sociodemographic characteristics, clinical presentation, cyst morphology, and postoperative complications.
Study design
- Observational model
- Other
- Time perspective
- Other
- Target follow-up
- 12 Months
Who may qualify
- Ages
- 9 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- This retrospective, observational study was conducted on a total of 350 patients diagnosed with liver hydatid cysts. The study was carried out at multiple centers in Najaf City, Iraq, including major governmental surgical hospitals and specialized centers, covering the period from February 2021 to June 2024.
Key inclusion criteria (1 listed)
- All patients of any age or gender with a radiologically or surgically confirmed diagnosis of liver hydatid cyst
Key exclusion criteria (1 listed)
- Patients with hydatid cysts located exclusively in extra-hepatic sites (e.g., brain, lung, bone, spleen, or muscle). Patients with severe chronic comorbidities or incomplete medical records were also excluded to ensure data integrity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
To determine the epidemiological and clinical profile of patients diagnosed with liver hydatid cysts within the hospitals of Najaf City, Iraq.
Time frame: February 2021 to June 2024
This retrospective observational study analyzed the records of 350 patients treated for liver hydatid cysts across multiple hospitals in Najaf, Iraq, from February 2021 to June 2024.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2026.
- Individual participant dataSharing planned: Undecided. undecided
Related trials for Hydatid Cyst, Hepatic
Not yet recruitingEarly Phase 1
5G Remote Robotic Surgery for Hepatic Echinococcosis in High-Altitude Region
Hepatic Echinococcosis
RecruitingObservational study
IM Bands in Inactive Hepatic CE
Cystic Echinococcosis
Recruiting
Biliary Fistulas in Surgery of Liver Echinococcosis
Echinococcosis, Hepatic, Biliary Fistula
RecruitingObservational study
Presentation of Protoscolexes and Acephalocysts in the Fibrous Capsule Area of the Liver With Echinococcosis
Echinococcosis, Hepatic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hydatid Cyst, Hepatic, run by Al-Kafeel University at 1 site in Iraq.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To determine the epidemiological and clinical profile of patients diagnosed with liver hydatid cysts within the hospitals of Najaf City, Iraq. (time frame: February 2021 to June 2024). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.